FIRST REPORT OF HURTHLE CELL-CARCINOMA REVEALED BY OCTREOTIDE SCANNING

Citation
Cj. Wilson et al., FIRST REPORT OF HURTHLE CELL-CARCINOMA REVEALED BY OCTREOTIDE SCANNING, The Annals of otology, rhinology & laryngology, 107(10), 1998, pp. 847-850
Citations number
7
Categorie Soggetti
Otorhinolaryngology
ISSN journal
00034894
Volume
107
Issue
10
Year of publication
1998
Part
1
Pages
847 - 850
Database
ISI
SICI code
0003-4894(1998)107:10<847:FROHCR>2.0.ZU;2-V
Abstract
Octreotide is an 8-chain amino acid analog of somatostatin. Somatostat in and its receptors occur naturally in multiple sites within the body and serve a suppressive role in endocrine hormone release. When octre otide, which has a considerably longer half-life than somatostatin, is combined with a radioactive isotope, receptor-based imaging can be pe rformed to visualize tumors with high concentrations of somatostatin r eceptors. Tumors of neural crest origin - pituitary adenomas, islet ce ll tumors, medullary thyroid carcinomas, pheochromocytomas, carcinoids , and paragangliomas - all express high levels of somatostatin recepto rs. We present the first reported positive octreotide scan of a Hurthl e cell carcinoma of the thyroid and, more important, discuss the role of octreotide scanning in otolaryngology, which has not yet been revie wed by our literature.